[Pharmacokinetic and clinical studies of ceftriaxone in neonates]. 1988

T Nishimura, and T Takashima, and K Tabuki, and M Takagi
Department of Pediatrics, Osaka Medical College.

Pharmacokinetic and clinical studies on ceftriaxone (CTRX) in mature and premature neonates were carried out. The results are summarized as follows. The mean serum peak level of CTRX after intravenous administration at a single dose of 10 mg/kg in 4 to 13 day-old-neonates was 34.1 +/- 11.4 micrograms/ml at 30 minutes. The mean serum level at 12 hours after dosage was 11.1 +/- 2.1 micrograms/ml. The mean half-life time was 11.6 +/- 1.4 hours. Mean serum peak levels of CTRX after intravenous administration at a single dose of 20 mg/kg were 64.6 +/- 15.4 micrograms/ml in 1 to 3 day-old-neonates, 44.6 +/- 1.1 micrograms/ml in 5 day-old-neonates at 30 minutes. Mean serum levels at 12 hours after dosage in these two groups of neonates were 16.4 +/- 4.8 micrograms/ml and 12.4 +/- 2.5 micrograms/ml, respectively. Mean half-life times were 13.7 +/- 3.7 hours in 1 to 3 day-old-neonates and 10.2 +/- 1.3 hours in 5 day-old-neonates. CTRX was clinically effective in a case of urinary tract infection. No side effect was observed except an elevation of GOT.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007234 Infant, Premature A human infant born before 37 weeks of GESTATION. Neonatal Prematurity,Premature Infants,Preterm Infants,Infant, Preterm,Infants, Premature,Infants, Preterm,Premature Infant,Prematurity, Neonatal,Preterm Infant
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D002443 Ceftriaxone A broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears. Benaxona,Cefatriaxone,Cefaxona,Ceftrex,Ceftriaxon,Ceftriaxon Curamed,Ceftriaxon Hexal,Ceftriaxona Andreu,Ceftriaxona LDP Torlan,Ceftriaxone Irex,Ceftriaxone Sodium,Ceftriaxone Sodium, Anhydrous,Ceftriaxone, Disodium Salt,Ceftriaxone, Disodium Salt, Hemiheptahydrate,Lendacin,Longacef,Longaceph,Ro 13-9904,Ro-13-9904,Ro13-9904,Rocefalin,Rocefin,Rocephin,Rocephine,Tacex,Terbac,Anhydrous Ceftriaxone Sodium,Ro 13 9904,Ro 139904,Ro13 9904,Ro139904
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection

Related Publications

T Nishimura, and T Takashima, and K Tabuki, and M Takagi
March 1988, The Japanese journal of antibiotics,
T Nishimura, and T Takashima, and K Tabuki, and M Takagi
March 1988, The Japanese journal of antibiotics,
T Nishimura, and T Takashima, and K Tabuki, and M Takagi
March 1988, The Japanese journal of antibiotics,
T Nishimura, and T Takashima, and K Tabuki, and M Takagi
March 1988, The Japanese journal of antibiotics,
T Nishimura, and T Takashima, and K Tabuki, and M Takagi
February 1988, The Japanese journal of antibiotics,
T Nishimura, and T Takashima, and K Tabuki, and M Takagi
February 1988, The Japanese journal of antibiotics,
T Nishimura, and T Takashima, and K Tabuki, and M Takagi
March 1990, The Japanese journal of antibiotics,
T Nishimura, and T Takashima, and K Tabuki, and M Takagi
March 1990, The Japanese journal of antibiotics,
T Nishimura, and T Takashima, and K Tabuki, and M Takagi
August 1988, The Japanese journal of antibiotics,
T Nishimura, and T Takashima, and K Tabuki, and M Takagi
March 1990, The Japanese journal of antibiotics,
Copied contents to your clipboard!